谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase 1 Combination Study of the CHK1 Inhibitor Prexasertib and the PARP Inhibitor Olaparib in High-grade Serous Ovarian Cancer and Other Solid Tumors

Khanh T. Do,Bose Kochupurakkal,Sarah Kelland,Adrienne de Jonge,Jennifer Hedglin,Allison Powers, Nicholas Quinn,Courtney Gannon, Loan Vuong,Kalindi Parmar,Jean-Bernard Lazaro,Alan D. D'Andrea,Geoffrey I. Shapiro

CLINICAL CANCER RESEARCH（2021）

引用 45|浏览12
暂无评分
关键词
PARP Inhibitors,Ovarian Cancer,Breast Cancer,Olaparib,cancer susceptibility
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要